Literature DB >> 7632529

Acute renal failure in a child associated with acyclovir.

P Vachvanichsanong1, P Patamasucon, M Malagon, E S Moore.   

Abstract

A 9-year-old boy developed acute renal failure following intravenous acyclovir (30 mg/kg per day) administered for 6 days to treat herpetic encephalitis. Physical findings and urine output were normal, except for increasing blood urea nitrogen (BUN), serum creatinine and mild proteinuria. Acyclovir was discontinued. However BUN and serum creatinine continued to increase and peaked on the following day at 8.6 mmol/l of urea (24 mg/dl) and 194 mumol/l (2.2 mg/ml), respectively. Conservative treatment and hydration were carried out. The kidney function returned to normal within 1 week. The use of acyclovir when necessary in renal failure patients is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632529     DOI: 10.1007/bf02254206

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  10 in total

1.  Acyclovir-induced renal failure: course and risk factors.

Authors:  M G Bianchetti; C Roduit; O H Oetliker
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

2.  Acute renal failure induced by oral acyclovir.

Authors:  E Hernandez; M Praga; F Moreno; C Montoyo
Journal:  Clin Nephrol       Date:  1991-09       Impact factor: 0.975

3.  Reversible ceftriaxone-associated biliary pseudolithiasis in children.

Authors:  U B Schaad; J Wedgwood-Krucko; H Tschaeppeler
Journal:  Lancet       Date:  1988-12-17       Impact factor: 79.321

4.  A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

Authors:  G J Schwartz; G B Haycock; C M Edelmann; A Spitzer
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

5.  Low-dose acyclovir and acute renal failure.

Authors:  A Giustina; G Romanelli; A Cimino; G Brunori
Journal:  Ann Intern Med       Date:  1988-02       Impact factor: 25.391

6.  Assessment of proteinuria using random urine samples.

Authors:  M Houser
Journal:  J Pediatr       Date:  1984-06       Impact factor: 4.406

7.  Acyclovir-induced renal failure. Clinical course and histology.

Authors:  M H Sawyer; D E Webb; J E Balow; S E Straus
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

8.  Renal function after acyclovir intravenous injection.

Authors:  D Brigden; A E Rosling; N C Woods
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

9.  Acyclovir tolerance in humans.

Authors:  R E Keeney; L E Kirk; D Bridgen
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

Review 10.  The mechanism of action, pharmacokinetics and toxicity of acyclovir--a review.

Authors:  D Brigden; P Whiteman
Journal:  J Infect       Date:  1983-05       Impact factor: 6.072

  10 in total
  6 in total

1.  Acute kidney injury due to acyclovir.

Authors:  Cigdem Yildiz; Yasemin Ozsurekci; Safak Gucer; Ali Bulent Cengiz; Rezan Topaloglu
Journal:  CEN Case Rep       Date:  2012-10-01

2.  Acute renal injury induced by valacyclovir hydrochloride: A case report.

Authors:  Yanning Zhang; Yuxi Cong; Yan Teng
Journal:  Exp Ther Med       Date:  2016-11-15       Impact factor: 2.447

Review 3.  Accidental and iatrogenic causes of acute kidney injury.

Authors:  Katherine Twombley; Michel Baum; Jyothsna Gattineni
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

4.  Determinants of aciclovir-induced nephrotoxicity in children.

Authors:  Ruth Schreiber; Jacob Wolpin; Gideon Koren
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

5.  The effect of acyclovir on the tubular secretion of creatinine in vitro.

Authors:  Patrina Gunness; Katarina Aleksa; Gideon Koren
Journal:  J Transl Med       Date:  2010-12-30       Impact factor: 5.531

6.  Risk Evaluation for Acute Kidney Injury Induced by the Concomitant Use of Valacyclovir, Analgesics, and Renin-Angiotensin System Inhibitors: The Detection of Signals of Drug-Drug Interactions.

Authors:  Ichiro Inaba; Yuki Kondo; Shinya Iwasaki; Satoko Tsuruhashi; Ayano Akaishi; Kazuya Morita; Kentaro Oniki; Junji Saruwatari; Yoichi Ishitsuka; Tetsumi Irie
Journal:  Front Pharmacol       Date:  2019-08-08       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.